OKYO Pharma (OKYO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Analysts Are Bullish on These Healthcare Stocks: Veru (VERU), Ascendis Pharma (ASND)December 20 at 7:24 PM | markets.businessinsider.comOKYO Pharma to Present at International Tear Film and Ocular Surface Society ConferenceOctober 30, 2024 | markets.businessinsider.comOkyo Pharma announces first patient dosed in Phase 2 trial of OK-101October 23, 2024 | markets.businessinsider.comOptimistic Buy Rating for OKYO Pharma Limited Driven by Promising Phase 2 Trial of OK-101 in Unmet Medical Need for Neuropathic Corneal PainOctober 16, 2024 | markets.businessinsider.comOKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal PainOctober 16, 2024 | finance.yahoo.comOKYO Pharma (NASDAQ:OKYO) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comOKYO Pharma Granted U.S. Patent Covering OK-101's Potential for Treating Symptoms of Dry Eye DiseaseAugust 27, 2024 | finanznachrichten.deInvesco Global Equity Income Trust Plc - Transaction in Own SharesAugust 15, 2024 | uk.finance.yahoo.comA mysterious pile of bones could hide evidence of Japanese war crimes, activists sayJuly 27, 2024 | msn.comTokyo stocks end mixed on rising interest rates, firm U.S. futuresMay 28, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: Curaleaf Holdings (OtherCURLF) and Aslan Pharmaceuticals (ASLN)May 3, 2024 | markets.businessinsider.comA second Kobayashi Pharma Japan factory inspected over deathsMarch 31, 2024 | msn.comJapanese authorities inspect second Kobayashi Pharma factory after deathsMarch 31, 2024 | msn.comKobayashi factory searched over deaths possibly linked to supplementsMarch 30, 2024 | msn.com5 dead and over 100 hospitalized from recalled Japanese health supplementsMarch 29, 2024 | msn.comWhat are 'beni-koji' products linked to Japan deaths?March 28, 2024 | msn.comA Japanese supplement pill is recalled after two people died and more than 100 were hospitalizedMarch 27, 2024 | msn.comUnicycive rises 4% on $50M private placementMarch 14, 2024 | msn.comPeople in Japan more worried about smell of others' excrement than their own: surveyMarch 3, 2024 | msn.com1 in 4 Japan primary school kids with hay fever's itchy eyes have trouble studyingFebruary 23, 2024 | msn.comOKYO Pharma Stock (NASDAQ:OKYO), Short Interest ReportFebruary 22, 2024 | benzinga.comOKYO Pharma gains on receiving FDA nod of IND for OK-101 in neuropathic corneal painFebruary 9, 2024 | msn.comOKYO Shares Rise 12% After FDA Clearance for IND ApplicationFebruary 9, 2024 | morningstar.comOKYO Pharma Says Phase 2 Study Of OK-101 Did Not Meet Primary GoalJanuary 8, 2024 | markets.businessinsider.comOKYO Pharma to Present at the Biotech Showcase Conference in San Francisco, January 8-10, 2024January 5, 2024 | finance.yahoo.comEyepoint Pharmaceuticals stock soars on wet-AMD trial resultsDecember 4, 2023 | proactiveinvestors.comOKYO Pharma Announces Last Patient Enrolled in OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease Has Completed Final Protocol VisitDecember 4, 2023 | finance.yahoo.comHC Wainwright & Co. Initiates Coverage of OKYO Pharma Limited - (OKYO) with Buy RecommendationNovember 3, 2023 | msn.comOKYO Pharma raises $5.84m via share issuanceOctober 31, 2023 | proactiveinvestors.comOKYO Pharma Announces $5.84 Million Cash Raise and Payables ReductionOctober 31, 2023 | finanznachrichten.deDry Eye Disease Affects Around 50M Americans, OKYO Pharma's Candidate Shows Safety In Mid-Stage StudyOctober 5, 2023 | msn.comOKYO shares retreat 12% after rallying ahead of Phase 2 study updateOctober 5, 2023 | msn.comOKYO Pharma Reports Positive Safety Data Profile For OK-101 In Dry Eye DiseaseOctober 5, 2023 | markets.businessinsider.comOKYO Pharma phase II dry eye trial making encouraging progressOctober 5, 2023 | proactiveinvestors.comOKYO Pharma Announces Positive Safety Data Profile for the ongoing OK-101 Phase 2 Clinical Trial to Treat Dry Eye Disease ("DED")October 5, 2023 | finance.yahoo.comOKYO Pharma closes $4M registered direct offeringSeptember 15, 2023 | proactiveinvestors.comOKYO Pharma Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary SharesSeptember 14, 2023 | finance.yahoo.comOKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease (“DED”)August 30, 2023 | uk.finance.yahoo.comOKYO Pharma regains compliance with Nasdaq listing minimum...OKYO Pharma regains compliance with Nasdaq listing minimum market...August 29, 2023 | proactiveinvestors.comOKYO Pharma Shares Rise 15% After Regaining Nasdaq ComplianceAugust 29, 2023 | marketwatch.comOKYO Pharma withdraws public offerAugust 1, 2023 | proactiveinvestors.comStocks to Watch: Barnes & Noble Education, HomeStreet and OKYO PharmaJuly 28, 2023 | marketwatch.comOKYO Pharma Limited Receives Nasdaq Deficiency NoticeJuly 28, 2023 | finance.yahoo.comOKYO Pharma Announces Proposed Public Offering of Ordinary SharesJuly 28, 2023 | finance.yahoo.comEye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?May 30, 2023 | benzinga.comOKYO Pharma LTD: OKYO Pharma Now Participating on the Webull Corporate Communications Service PlatformMay 11, 2023 | finanznachrichten.deOKYO Pharma Now Participating on the Webull Corporate Communications Service PlatformMay 11, 2023 | finance.yahoo.comGoldman Small Cap Research Publishes New Research Report on OKYO Pharma LimitedMay 9, 2023 | finance.yahoo.comOKYO Pharma reaches milestone with first patient screening for dry eye disease trialMay 2, 2023 | proactiveinvestors.comOKYO Pharma screens first patient for dry eye disease trialMay 2, 2023 | proactiveinvestors.com Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private. Click here to see Dan's full warning to the public. OKYO Media Mentions By Week OKYO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OKYO News Sentiment▼0.000.61▲Average Medical News Sentiment OKYO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OKYO Articles This Week▼10▲OKYO Articles Average Week Get OKYO Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for OKYO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pharos Energy News Today Kodal Minerals News Today Aura Energy News Today Marks Electrical Group News Today Revolution Beauty Group News Today CyanConnode News Today OptiBiotix Health News Today Altitude Group News Today Origin Enterprises News Today Guild Esports News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:OKYO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OKYO Pharma Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share OKYO Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.